Search
Close this search box.

Pakistan

EZVIZ breaks new ground in outdoor security with the 4G & Wi-Fi battery camera family, addressing everyday challenges while inspiring new scenarios from homes to wilderness

February 2, 2026

EZVIZ 4G & Wi-Fi Battery Camera Family Hot Debut RIYADH, Saudi Arabia, Feb. 02, 2026 (GLOBE NEWSWIRE) — EZVIZ, recognized for reshaping the smart security landscape with its pioneering technologies, reinvents a familiar favorite with the debut of its 4G & Wi-Fi battery camera family. By weaving dual 4G & Wi-Fi flexibility with refined video […]

Details on the timetable of the simplified tender offer on North Atlantic Energies shares

January 31, 2026

Paris, Jan. 30, 2026 (GLOBE NEWSWIRE) — NORTH ATLANTIC ENERGIES Details on the timetable of the simplified tender offer on North Atlantic Energies shares Paris, FRANCE – January 30, 2026 – North Atlantic France SAS (“North Atlantic France”) refers to its acquisition from ExxonMobil France Holding SAS (“ExxonMobil”) of ExxonMobil’s entire stake in North Atlantic Energies […]

Details on the timetable of the simplified tender offer on North Atlantic Energies shares

January 31, 2026

Paris, Jan. 30, 2026 (GLOBE NEWSWIRE) — NORTH ATLANTIC ENERGIES Details on the timetable of the simplified tender offer on North Atlantic Energies shares Paris, FRANCE – January 30, 2026 – North Atlantic France SAS (“North Atlantic France”) refers to its acquisition from ExxonMobil France Holding SAS (“ExxonMobil”) of ExxonMobil’s entire stake in North Atlantic Energies […]

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

January 30, 2026

Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy directly targeting the OX40 receptor expressed on pathogenic T-cells shows potential to deliver long-term disease control in patients with moderate-to-severe atopic dermatitis (msAD). Regulatory submission is planned in the first […]

Feature Posts

Categories
Adverstisement
Recent Posts
Pages
Copyright © 2026 pressarabia All Rights Reserved.